Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire6 November 2025ResumeBuilder.com Survey: 1 in 3 Dating App Users Are Swiping for Jobs, Not Love
Many users are leveraging dating apps for networking, mentorship, and even job offers GUAYNABO, Puerto Rico, Nov. 6, 2025 /PRNewswire/…
Read More » -
Cision PR Newswire6 November 2025Viking Therapeutics Highlights Clinical Data from VK2735 Obesity Program in Presentation at ObesityWeek® 2025
VENTURE Study Exploratory Analysis Shows VK2735 Improved Cardiometabolic Parameters After 13 Weeks; Reducing Prediabetes and Metabolic Syndrome SAN DIEGO, Nov.…
Read More » -
Business Wire6 November 2025
Tradeweb Reports October 2025 Total Trading Volume of $65.4 Trillion and Average Daily Volume of $2.8 Trillion
October 2025 ADV up 20.7% YoY NEW YORK–(BUSINESS WIRE)–Tradeweb Markets Inc. (Nasdaq: TW), a leading, global operator of electronic marketplaces…
Read More » -
Business Wire6 November 2025
Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025
– Company to host conference call and webcast at 8:00 a.m. ET on Thursday, November 13, 2025 – TORONTO–(BUSINESS WIRE)–Cybin…
Read More » -
Business Wire6 November 2025
NUBURU Strengthens Balance Sheet, Advances Defense-Tech Acquisition Program and Revamps Blue-Laser Business
Executing Transformation Plan spanning Maddox Defense drones, Tekne special-mission vehicles, and Orbit critical-infrastructure software to build a unified defense-tech platform…
Read More » -
Business Wire6 November 2025
Silence Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights
SANRECO Phase 2 study of divesiran in polycythemia vera (PV) fully enrolled; topline results anticipated in 3Q 2026 Strong balance…
Read More » -
Business Wire6 November 2025
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
JERSEY CITY, N.J.–(BUSINESS WIRE)–Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its…
Read More » -
Cision PR Newswire6 November 2025REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights
RGX-202 program for Duchenne muscular dystrophy advancing rapidly, topline results expected early Q2 2026 and BLA submission mid-2026 Pivotal trial enrollment…
Read More » -
Cision PR Newswire6 November 2025Tripadvisor, Inc. Earnings Press Release Available on Company’s Investor Relations Site
NEEDHAM, Mass., Nov. 6, 2025 /PRNewswire/ — Tripadvisor, Inc. (NASDAQ: TRIP) issued its third quarter 2025 earnings press release which…
Read More » -
Cision PR Newswire6 November 2025Mwyngil Therapeutics Announces In-Licensing of GPR75 Modulators and Cell-Surface Discovery Platform from Expert Systems Inc.
DOVER, Del., Nov. 6, 2025 /PRNewswire/ — Mwyngil Therapeutics Inc., a biopharmaceutical company dedicated to developing first-in-class and best-in-class small-molecule therapies…
Read More »